Updated: BioSpace's List of November 2018 Life Sciences IPOs
November 2018 IPO Filings and Proceeds, Updated 11/30/18
Know of an IPO since Nov. 1, 2018 that we missed? Email us at firstname.lastname@example.org.
Related: Check out BioSpace's October IPO list here.
|Date||Company Name||Amount (USD)||Company HQ||Research Focus|
|11/21/18||Taiwan Liposome Company||$21.8M Priced||Taipei, Taiwan||Lipid-assembled drug delivery platform with approved active pharmaceutical ingredients|
|11/20/18||Tiziana Life Sciences Plc||$4.38M Priced||London, UK||Therapeutics and diagnostics for cancers, autoimmune diseases, and inflammation|
|11/13/18||Synthorx, Inc.||$100M Filed||La Jolla, CA||Designing and building protein therapeutics to treat cancer and autoimmune disorders|
|11/13/18||Vapotherm Inc.||$56M Priced||Exeter, NH||Hi-VNI® technology company for respiratory distress|
|11/12/18||Eton Pharmaceuticals||$21.6M Priced||Deer Park, IL||Developing products, that have previously been FDA approved, for new diseases|
|11/9/18||Moderna Therapeutics||$500M Filed||Cambridge, MA||mRNA medicines used to eventually prevent, treat, or cure disease|
|11/9/18||DiaMedica Therapeutics||$15M Filed||Minneapolis, MN||DM199, a recombinant human protein, for neurological and kidney diseases|
|11/5/18||Eton Pharmaceuticals||$21.6M Filed||Deer Park, IL||Developing products, that have previously been FDA approved, for new diseases|